Pharmaceutical Intermediates Global Market Report 2024

Description

Pharmaceutical intermediates are chemical compounds or substances used in the synthesis and production of active pharmaceutical ingredients (APIs) or drug substances. These intermediates play a crucial role in the development and production of a wide range of drugs and therapeutic products, and they are utilized by pharmaceutical companies and research institutions.

The main types of pharmaceutical intermediates products include chemical intermediates, bulk drug intermediates, and other products. Chemical intermediates are compounds or substances produced during the manufacturing process of chemicals and find applications in various industries, including pharmaceuticals, agrochemicals, polymers, and specialty chemicals. Categories of pharmaceutical intermediates include branded drug intermediates and generic drug intermediates. The applications of pharmaceutical intermediates cover various drugs such as analgesics, anti-infective drugs, cardiovascular drugs, oral antidiabetic drugs, antimicrobial drugs, and others. The end-users of pharmaceutical intermediates include biotech and pharma companies, research institutions, and others.

The pharmaceutical intermediates market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical intermediates market statistics, including pharmaceutical intermediates industry global market size, regional shares, competitors with a pharmaceutical intermediates market share, detailed pharmaceutical intermediates market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceutical intermediates industry. This pharmaceutical intermediate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical intermediates market size has grown strongly in recent years. It will grow from $31.33 billion in 2023 to $33.59 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth observed in the historical period can be attributed to various factors, including advancements in chemical synthesis techniques, the evolution of drug development processes, market demand and expansion, increased investment in research and development, and adherence to regulatory compliance standards.

The pharmaceutical intermediates market size is expected to see strong growth in the next few years. It will grow to $43.01 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth in the forecast period can be attributed to factors such as innovation in biopharmaceuticals, the development of precision medicine, initiatives in green chemistry, the production of customized intermediates, and prevailing trends in pharmaceutical outsourcing. Noteworthy trends expected in the forecast period encompass the adoption of continuous flow chemistry, increased use of automation and robotics, the application of nanotechnology, advancements in biocatalysis and enzyme engineering, and the implementation of strategic supply chain management in the pharmaceutical intermediates sector.

The anticipated increase in the prevalence of chronic diseases is poised to drive the growth of the pharmaceutical intermediates market in the foreseeable future. Chronic diseases, characterized by lasting three months or longer and having the potential to worsen over time, are on the rise due to factors such as an aging population, lifestyle changes, rapid urbanization, and insufficient preventive measures. In March 2022, the National Institute of Health reported that chronic kidney disorders are expected to affect 13.4% of the population, with an estimated 4.902 to 7.083 million individuals requiring renal replacement therapy for end-stage kidney disease (ESKD). Pharmaceutical intermediates play a vital role in developing medications used to manage chronic diseases, mitigating the escalating prevalence of such conditions and consequently driving the pharmaceutical intermediates market's growth.

The expected increase in pharmaceutical drug production is set to propel the pharmaceutical intermediates market's expansion. Drug production involves the manufacturing process of pharmaceutical substances, medications, or drugs, and as pharmaceutical drugs become more complex and targeted, their synthesis requires multiple steps. Pharmaceutical intermediates are chemical compounds produced during these intermediate steps in the manufacturing process. The European Federation of Pharmaceutical Industries and Associations (EFPIA) reported in June 2022 that the total pharmaceutical production in Europe reached $351 billion (€300,000 million) in 2021, marking a 5% increase from $335.2 billion (€286,697 million) in 2020. The growing demand for pharmaceutical drugs is a key driver propelling the pharmaceutical intermediates market.

Leading companies in the pharmaceutical intermediates market are introducing new product lines, such as API Intermediates, to enhance their market position and profitability. API intermediates, which are chemical compounds used in the synthesis of active pharmaceutical ingredients (APIs), play a crucial role in producing medications for various therapeutic areas. In October 2023, Huateng Pharmaceutical Co. Ltd., a China-based pharmaceutical company, launched its Gastrointestinal API Intermediates product line. These intermediates serve as building blocks for pharmaceutical active ingredients used in medications treating gastrointestinal system disorders, including laxatives, 5-HT3 receptor antagonists, H2-receptor antagonists, and proton pump inhibitors.

Major players in the pharmaceutical intermediates market are focusing on developing intermediates specifically for small molecule drugs. Intermediates are transitional products formed during different stages of the chemical manufacturing process before reaching the final active pharmaceutical ingredient (API) or drug substance, playing a crucial role in the synthesis of small molecule drugs. Sumitomo Chemical Co., Ltd., a Japan-based chemical company, launched active pharmaceutical ingredients (APIs) and intermediates for small molecule drugs in March 2022. This initiative aims to meet the growing demand for small molecule medications by offering a broader range of premium APIs and intermediates.

In May 2021, Aceto Corporation, a US-based provider of specialty materials, acquired Finar Limited, an India-based manufacturer and supplier of high-purity solvents and chemicals. This acquisition aligns with Aceto's growth strategy, enhancing its manufacturing footprint, research and development (R&D) capabilities, and quality expertise in the pharmaceutical intermediates market. The collaboration with Finar Limited allows Aceto to expand its product offerings and strengthen its position in the industry.

Major companies operating in the pharmaceutical intermediates market report are BASF SE, Sanofi SA, Thermo Fisher Scientific Inc., Merck KGaA, Dishman Carbogen Amcis Ltd., Evonik Industries AG, Arkema Inc., Lonza Group AG, Wuxi AppTec co. Ltd., Aurobindo Pharma Limited, Lianhe Chemical Technology Co. Ltd., Cambrex Corporation, Vertellus Holdings LLC., Hovione LLC, Hikal Ltd., Codexis Inc., Aceto Corporation, Interchem Corporation, Midas Pharma GmbH, Arbiom, Dextra Laboratories Ltd., A. R. Life Sciences, Ingenza Ltd., Chiracon GmbH, Dyadic International Inc., Elam Pharma Pvt Ltd., Yin-sheng Bio-tech Co. Ltd., Green Vision Life Sciences, Sibylla Biotech s.r.l., Pfizer CentreOne

North America was the largest region in the pharmaceutical intermediates market in 2023. The regions covered in the pharmaceutical intermediates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical intermediates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical intermediates market consists of sales of intermediates for API synthesis, API precursors, fine chemicals, and specialty chemicals. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Intermediates Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical intermediates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical intermediates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical intermediates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product: Chemical Intermediate; Bulk Drug Intermediate; Other Products
2) By Category: Branded Drug Intermediate; Generic Drug Intermediate
3) By Application: Analgesics; Anti-Infective Drugs; Cardiovascular Drugs; Oral Antidiabetic Drugs; Antimicrobial Drugs; Other Applications
4) By End-User: Biotech And Pharma Companies; Research Institutions; Other End-Users
Companies Mentioned: BASF SE; Sanofi SA; Thermo Fisher Scientific Inc; Merck KGaA; Dishman Carbogen Amcis Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13804

1. Executive Summary

2. Pharmaceutical Intermediates Market Characteristics

3. Pharmaceutical Intermediates Market Trends And Strategies

4. Pharmaceutical Intermediates Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Pharmaceutical Intermediates Market Size and Growth

5.1. Global Pharmaceutical Intermediates Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Pharmaceutical Intermediates Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Pharmaceutical Intermediates Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical Intermediates Market Segmentation

6.1. Global Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chemical Intermediate
Bulk Drug Intermediate
Other Products
6.2. Global Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Branded Drug Intermediate
Generic Drug Intermediate
6.3. Global Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Analgesics
Anti-Infective Drugs
Cardiovascular Drugs
Oral Antidiabetic Drugs
Antimicrobial Drugs
Other Applications
6.4. Global Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Biotech And Pharma Companies
Research Institutions
Other End-Users

7. Pharmaceutical Intermediates Market Regional And Country Analysis

7.1. Global Pharmaceutical Intermediates Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pharmaceutical Intermediates Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical Intermediates Market

8.1. Asia-Pacific Pharmaceutical Intermediates Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical Intermediates Market

9.1. China Pharmaceutical Intermediates Market Overview
9.2. China Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical Intermediates Market

10.1. India Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical Intermediates Market

11.1. Japan Pharmaceutical Intermediates Market Overview
11.2. Japan Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical Intermediates Market

12.1. Australia Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical Intermediates Market

13.1. Indonesia Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical Intermediates Market

14.1. South Korea Pharmaceutical Intermediates Market Overview
14.2. South Korea Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical Intermediates Market

15.1. Western Europe Pharmaceutical Intermediates Market Overview
15.2. Western Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical Intermediates Market

16.1. UK Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical Intermediates Market

17.1. Germany Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical Intermediates Market

18.1. France Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical Intermediates Market

19.1. Italy Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical Intermediates Market

20.1. Spain Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical Intermediates Market

21.1. Eastern Europe Pharmaceutical Intermediates Market Overview
21.2. Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical Intermediates Market

22.1. Russia Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical Intermediates Market

23.1. North America Pharmaceutical Intermediates Market Overview
23.2. North America Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical Intermediates Market

24.1. USA Pharmaceutical Intermediates Market Overview
24.2. USA Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical Intermediates Market

25.1. Canada Pharmaceutical Intermediates Market Overview
25.2. Canada Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical Intermediates Market

26.1. South America Pharmaceutical Intermediates Market Overview
26.2. South America Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical Intermediates Market

27.1. Brazil Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical Intermediates Market

28.1. Middle East Pharmaceutical Intermediates Market Overview
28.2. Middle East Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical Intermediates Market

29.1. Africa Pharmaceutical Intermediates Market Overview
29.2. Africa Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical Intermediates Market Competitive Landscape And Company Profiles

30.1. Pharmaceutical Intermediates Market Competitive Landscape
30.2. Pharmaceutical Intermediates Market Company Profiles
- 30.2.1. BASF SE
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Sanofi SA
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Thermo Fisher Scientific Inc
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck KGaA
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Dishman Carbogen Amcis Ltd
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Pharmaceutical Intermediates Market Other Major And Innovative Companies

31.1. Evonik Industries AG
31.2. Arkema Inc.
31.3. Lonza Group AG
31.4. Wuxi AppTec co. Ltd
31.5. Aurobindo Pharma Limited.
31.6. Lianhe Chemical Technology Co. Ltd.
31.7. Cambrex Corporation
31.8. Vertellus Holdings LLC.
31.9. Hovione LLC
31.10. Hikal Ltd.
31.11. Codexis Inc.
31.12. Aceto Corporation
31.13. Interchem Corporation
31.14. Midas Pharma GmbH
31.15. Arbiom

32. Global Pharmaceutical Intermediates Market Competitive Benchmarking

33. Global Pharmaceutical Intermediates Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical Intermediates Market

35. Pharmaceutical Intermediates Market Future Outlook and Potential Analysis

35.1 Pharmaceutical Intermediates Market In 2028 - Countries Offering Most New Opportunities
35.2 Pharmaceutical Intermediates Market In 2028 - Segments Offering Most New Opportunities
35.3 Pharmaceutical Intermediates Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer